Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Brazil
Oxaliplatin

Anvisa 2020

Oxaliplatin

Eloxatin

BrazilAuthorisedAuthorised 17 Feb 2020

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

EloxatinCanada · 50 MG / VIAL · Powder For Solution · Sanofi-Aventis Canada INCSame brand
EloxatinCanada · 5 MG / ML · Solution · Sanofi-Aventis Canada INCSame brand
EloxatinCanada · 100 MG / VIAL · Powder For Solution · Sanofi-Aventis Canada INCSame brand
Eloxatin 100MG VialSaudi Arabia · Sanofi aventis Deutschland GmbHSame brand
Eloxatin 100MG VialSaudi Arabia · Aventis Pharma LimitedSame brand
Eloxatin 50MG VialSaudi Arabia · Aventis Pharma LimitedSame brand
Eloxatin 5mg/ml Concentrate for solution for infusionSingapore · 5mg/ml · injection, solution, concentrate · Sanofi-Aventis Singapore Pte. LTD.Same brand

More with the same substance on this register

CollectroOxaliplatinBrazil
CollectroOxaliplatinBrazil

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇺🇸EloxatinUnited States · 100MG/20ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness r · injectable · Sanofi Aventis USSame brand

🇭🇷Oxaliplatin Kabi 5 mg/ml koncentrat za otopinu za infuzijuCroatia · koncentrat za otopinu za infuziju · Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, HrvatskaSame form

🇭🇷Oxaliplatin Pliva 5 mg/ml koncentrat za otopinu za infuzijuCroatia · koncentrat za otopinu za infuziju · Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, HrvatskaSame form

🇭🇷Oxaliplatin Kabi 5 mg/ml koncentrat za otopinu za infuziju [paralelni uvoz]Croatia · Koncentrat za otopinu za infuziju · Delecto Firmus d.o.o., Kutnjački put 18, Zagreb, HrvatskaSame form

🇷🇴OXALIPLATIN ACCORD 5 mg/mlRomania · 5 mg/ml · conc. pt. sol. perf. · Accord Healthcare Polska SP Z.O.O.Same form

🇷🇴OXALIPLATIN ACCORD 5mg/mlRomania · 5mg/ml · conc. pt. sol. perf. · Accord Healthcare LimitedSame form

🇷🇴OXALIPLATIN KABI 5 mg/mlRomania · 5mg/ml · conc. pt. sol. perf. · Fresenius Kabi Romania SRLSame form

🇹🇼Olatin I.V. Injection 5mg/mlTaiwan · 注射劑 · 美時化學製藥股份有限公司Same form

🇪🇸OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGSpain · 5 mg · concentrado para solución para perfusión · Accord Healthcare S.L.U.Same substance

🇪🇸Oxaliplatino Aurovit 5 MG/ML Concentrado Para Solucion Para Perfusion EfgSpain · 5 mg · concentrado para solución para perfusión · Eugia Pharma (Malta) LimitedSame substance

🇪🇸Oxaliplatino Hikma 5 MG/ML Concentrado Para Solucion Para Perfusion EfgSpain · 5 mg/ml · concentrado para solución para perfusión · Hikma Farmaceutica (Portugal) S.A.Same substance

🇮🇹Oxaliplatino AccordItaly · Concentrato per soluzione per infusione · Accord Healthcare, S.L.U.Same substance

🇮🇹Oxaliplatino Aurobindo ItaliaItaly · Concentrato per soluzione per infusione · Eugia Pharma (Malta) LimitedSame substance

🇮🇹Oxaliplatino Fosun PharmaItaly · Concentrato per soluzione per infusione · Fosun Pharma SP ZooSame substance

🇳🇱Oxaliplatine Accord 5 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Accord Healthcare B.V.Same substance

🇳🇱Oxaliplatine Fresenius Kabi 5 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Fresenius Kabi Nederland B.V.Same substance

🇳🇱Oxaliplatine Hikma 5 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Hikma Farmaceutica (Portugal), S.A.Same substance

🇳🇿Alchemy OxaliplatinNew Zealand · Inj 5 mg per ml, 20 ml vialSame substance

🇳🇿Oxaliplatin AccordNew Zealand · Inj 5 mg per ml, 20 ml vialSame substance

🇳🇿Oxaliplatin Actavis 100New Zealand · Inj 100 mg vialSame substance

🇷🇸Oksaliplatin AccordSerbia · 5mg/ml · koncentrat za rastvor za infuziju · Evropa Lek Pharma D.O.O. BeogradSame substance

🇷🇸Oksaliplatin AccordSerbia · 5mg/ml · koncentrat za rastvor za infuziju · Evropa Lek Pharma D.O.O. BeogradSame substance

🇷🇸Oksaliplatin AccordSerbia · 5mg/ml · koncentrat za rastvor za infuziju · Evropa Lek Pharma D.O.O. BeogradSame substance

🇸🇬Hovid Oxaliplatin Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100 mg/vial · injection, powder, lyophilized, for solution · Goldplus Universal Pte LTDSame substance

🇸🇬Hovid Oxaliplatin Powder for Concentrate for Solution for Infusion 50MG/VialSingapore · 50 mg/vial · injection, powder, lyophilized, for solution · Goldplus Universal Pte LTDSame substance

🇺🇸OxaliplatinUnited States · 100MG/20ML, 100MG/VIAL, 200MG/40ML … · injectable · Fresenius Kabi USASame substance

🇺🇸OxaliplatinUnited States · 5MG/ML · injectable · Mustafa Nevsat Iiac Sanayii A.S.Same substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Oxaliplatin
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 17 Feb 2020
Registration: 183260426
Marketing authorisation holder: Sanofi Medley Farmacêutica Ltda.
Procedure: Registered

Anvisa

EvoxaliOxaliplatin🇧🇷Brazil

AnvisaOxaOxaliplatin🇧🇷Brazil

AnvisaOxa-PlatinOxaliplatin🇧🇷Brazil

AnvisaOxa-PlatinOxaliplatin🇧🇷Brazil

AnvisaOxalibbsOxaliplatin🇧🇷Brazil

AnvisaOxalimeizOxaliplatin🇧🇷Brazil

AnvisaoxaliplatinaOxaliplatin🇧🇷Brazil

AnvisaoxaliplatinaOxaliplatin🇧🇷Brazil

AnvisaOxaliplatinaOxaliplatin🇧🇷Brazil

AnvisaOxaliplatinaOxaliplatin🇧🇷Brazil